{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:07:15Z","timestamp":1788260835249,"version":"build-2803163510"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Basic Research Program of Jiangsu Province-Project of Youth Foundation","award":["BK20220658"],"award-info":[{"award-number":["BK20220658"]}]},{"name":"Natural Science Foundation of Basic Research Program of Jiangsu Province-Project of Youth Foundation","award":["D2021042"],"award-info":[{"award-number":["D2021042"]}]},{"name":"Excellent Talents Research Foundation of Xuzhou Medical University","award":["BK20220658"],"award-info":[{"award-number":["BK20220658"]}]},{"name":"Excellent Talents Research Foundation of Xuzhou Medical University","award":["D2021042"],"award-info":[{"award-number":["D2021042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cuproptosis, a new cell death pattern, is promising as an intervention target to treat tumors. Abnormal long non-coding RNA (lncRNA) expression is closely associated with the occurrence and development of papillary renal cell carcinoma (pRCC). However, cuproptosis-related lncRNAs (CRLs) remain largely unknown as prognostic markers for pRCC. We aimed to forecast the prognosis of pRCC patients by constructing models according to CRLs and to examine the correlation between the signatures and the inflammatory microenvironment. From the Cancer Genome Atlas (TCGA), RNA sequencing, genomic mutations and clinical data of TCGA-KIRP (Kidney renal papillary cell carcinoma) were analyzed. Randomly selected pRCC patients were allotted to the training and testing sets. To determine the independent prognostic impact of the training characteristic, the least absolute shrinkage and selection operator (LASSO) algorithm was utilized, together with univariate and multivariate Cox regression models. Further validation was performed in the testing and whole cohorts. External datasets were utilized to verify the prognostic value of CRLs as well. The CRLs prognostic features in pRCC were established based on the five CRLs (AC244033.2, LINC00886, AP000866.1, MRPS9-AS1 and CKMT2-AS1). The utility of CRLs was evaluated and validated in training, testing and all sets on the basis of the Kaplan\u2013Meier (KM) survival analysis. The risk score could be a robust prognostic factor to forecast clinical outcomes for pRCC patients by the LASSO algorithm and univariate and multivariate Cox regression. Analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) data demonstrated that differentially expressed genes (DEGs) are primarily important for immune responses and the PI3K-Akt pathway. Arachidonic acid metabolism was enriched in the high-risk set by Gene Set Enrichment Analysis (GSEA). In addition, Tumor Immune Dysfunction and Exclusion (TIDE) analysis suggested that there was a high risk of immune escape in the high-risk cohort. The immune functions of the low- and high-risk sets differed significantly based on immune microenvironment analysis. Finally, four drugs were screened with a higher sensitivity to the high-risk set. Taken together, a novel model according to five CRLs was set up to forecast the prognosis of pRCC patients, which provides a potential strategy to treat pRCC by a combination of cuproptosis and immunotherapy.<\/jats:p>","DOI":"10.3390\/ijms24021464","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T01:32:26Z","timestamp":1673487146000},"page":"1464","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma"],"prefix":"10.3390","volume":"24","author":[{"given":"Yipeng","family":"Pang","sequence":"first","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-5278","authenticated-orcid":false,"given":"Wenlong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"},{"name":"Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urolonc.2021.04.013","article-title":"Papillary renal cell carcinoma: Review","volume":"39","author":"Mendhiratta","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rysz, J., Franczyk, B., Lawinski, J., and Gluba-Brzozka, A. (2021). Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010151"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAP.0000000000000220","article-title":"Papillary Renal Cell Carcinoma (PRCC): An Update","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"370 e321","DOI":"10.1016\/j.urolonc.2021.02.003","article-title":"Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional series","volume":"39","author":"Steward","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAS.0000000000001802","article-title":"Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease","volume":"46","author":"Chan","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2014.05.010","article-title":"Systemic therapy for non-clear cell renal cell carcinomas: A systematic review and meta-analysis","volume":"67","author":"Templeton","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","article-title":"Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies","volume":"17","author":"Makhov","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"711227","DOI":"10.3389\/fmolb.2021.711227","article-title":"Role of Copper on Mitochondrial Function and Metabolism","volume":"8","author":"Ruiz","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000499261","article-title":"Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients","volume":"14","author":"Saleh","year":"2020","journal-title":"Curr. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/cmdc.202100172","article-title":"Copper: An Intracellular Achilles\u2019 Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics","volume":"16","author":"Michniewicz","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1038\/s41467-020-17549-y","article-title":"Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"841814","DOI":"10.3389\/fmolb.2022.841814","article-title":"Selective Targeting of Cancer Cells by Copper Ionophores: An Overview","volume":"9","author":"Oliveri","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"910928","DOI":"10.3389\/fmolb.2022.910928","article-title":"Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-induced cell death","volume":"375","author":"Kahlson","year":"2022","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","article-title":"Long non-coding RNAs: A new frontier in the study of human diseases","volume":"339","author":"Shi","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fnins.2019.01320","article-title":"Dysregulated Long Non-coding RNAs in Parkinson\u2019s Disease Contribute to the Apoptosis of Human Neuroblastoma Cells","volume":"13","author":"Fan","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ruan, X., Li, P., Ma, Y., Jiang, C.F., Chen, Y., Shi, Y., Gupta, N., Seifuddin, F., Pirooznia, M., and Ohnishi, Y. (2021). Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis. J. Clin. Investig., 131.","DOI":"10.1172\/JCI136336"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-021-03958-4","article-title":"SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155\/HIF-1alpha signaling","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41419-020-2713-8","article-title":"Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-021-03955-7","article-title":"LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p\/E2F2 axis in renal cell carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"958547","DOI":"10.3389\/fgene.2022.958547","article-title":"Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma","volume":"13","author":"Huili","year":"2022","journal-title":"Front. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1038\/s41598-022-15251-1","article-title":"A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12957-022-02727-7","article-title":"Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma","volume":"20","author":"Wang","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"961213","DOI":"10.3389\/fonc.2022.961213","article-title":"Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"957966","DOI":"10.3389\/fonc.2022.957966","article-title":"A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer","volume":"12","author":"Feng","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S1470-2045(15)00290-9","article-title":"Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: A randomised, phase 2, open-label, multicentre trial","volume":"16","author":"Motzer","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.critrevonc.2015.05.008","article-title":"Papillary renal cell carcinoma: A review of the current therapeutic landscape","volume":"96","author":"Courthod","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2019.07.020","article-title":"Toward a genome-based treatment landscape for renal cell carcinoma","volume":"142","author":"Massari","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13528","DOI":"10.1021\/acs.inorgchem.9b01029","article-title":"Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit","volume":"58","author":"Hunsaker","year":"2019","journal-title":"Inorg. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Babak, M.V., and Ahn, D. (2021). Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080852"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"118893","DOI":"10.1016\/j.bbamcr.2020.118893","article-title":"Copper metabolism as a unique vulnerability in cancer","volume":"1868","author":"Shanbhag","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/iub.2341","article-title":"Copper homeostasis: Emerging target for cancer treatment","volume":"72","author":"Li","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12935-021-02247-6","article-title":"A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15359","DOI":"10.18632\/aging.103580","article-title":"Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10585-022-10171-w","article-title":"Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7\/ELF3\/miR-144 pathway in esophageal squamous cell carcinoma","volume":"39","author":"Dong","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"152877","DOI":"10.1016\/j.prp.2020.152877","article-title":"Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma","volume":"216","author":"Lan","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"788451","DOI":"10.3389\/fcell.2021.788451","article-title":"A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients","volume":"9","author":"He","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lin, Y., Xiao, Y., Liu, S., Hong, L., Shao, L., and Wu, J. (2022). Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. BMC Med. Genom., 15.","DOI":"10.1186\/s12920-022-01369-8"},{"key":"ref_41","first-page":"327","article-title":"Long Non-Coding RNA CKMT2-AS1 Reduces the Viability of Colorectal Cancer Cells by Targeting AKT\/mTOR Signaling Pathway","volume":"51","author":"Zhuang","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway","volume":"142","author":"Polivka","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-015-4903-7","article-title":"Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status","volume":"23","author":"Shin","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/13543780902980171","article-title":"Sunitinib in solid tumors","volume":"18","author":"Gan","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13059-016-1047-4","article-title":"Erratum to: A survey of best practices for RNA-seq data analysis","volume":"17","author":"Conesa","year":"2016","journal-title":"Genome Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: An R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v050.i11","article-title":"Evaluating Random Forests for Survival Analysis using Prediction Error Curves","volume":"50","author":"Mogensen","year":"2012","journal-title":"J. Stat. Softw."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize Implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: An R\/Bioconductor package for disease ontology semantic and enrichment analysis","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_54","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1464\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:35Z","timestamp":1760119415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021464"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021464","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]}}}